In chronic myelogenous leukemia (CML) (Fig. 6), METTL3 decreases the expression of PTEN by increasing the m6A modification level of PTEN mRNA. The gene discussed is METTL3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.